TCM
XLRN
TimesSquare Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-392,500
| Closed | -$67.5M | – | 232 |
|
2021
Q3 | $67.5M | Sell |
392,500
-122,495
| -24% | -$21.1M | 0.59% | 59 |
|
2021
Q2 | $64.6M | Sell |
514,995
-152,015
| -23% | -$19.1M | 0.53% | 74 |
|
2021
Q1 | $90.5M | Sell |
667,010
-120,945
| -15% | -$16.4M | 0.77% | 34 |
|
2020
Q4 | $101M | Sell |
787,955
-63,900
| -8% | -$8.18M | 0.82% | 26 |
|
2020
Q3 | $95.9M | Sell |
851,855
-124,565
| -13% | -$14M | 0.9% | 24 |
|
2020
Q2 | $93M | Sell |
976,420
-22,900
| -2% | -$2.18M | 0.89% | 19 |
|
2020
Q1 | $89.8M | Sell |
999,320
-126,255
| -11% | -$11.3M | 1.07% | 13 |
|
2019
Q4 | $59.7M | Buy |
1,125,575
+76,675
| +7% | +$4.07M | 0.53% | 80 |
|
2019
Q3 | $41.4M | Buy |
1,048,900
+131,930
| +14% | +$5.21M | 0.37% | 110 |
|
2019
Q2 | $37.7M | Sell |
916,970
-3,745
| -0.4% | -$154K | 0.29% | 136 |
|
2019
Q1 | $42.9M | Buy |
920,715
+209,900
| +30% | +$9.78M | 0.33% | 129 |
|
2018
Q4 | $31M | Sell |
710,815
-27,300
| -4% | -$1.19M | 0.27% | 143 |
|
2018
Q3 | $42.2M | Buy |
738,115
+361,460
| +96% | +$20.7M | 0.28% | 141 |
|
2018
Q2 | $18.3M | Buy |
376,655
+44,650
| +13% | +$2.17M | 0.12% | 207 |
|
2018
Q1 | $13M | Buy |
+332,005
| New | +$13M | 0.09% | 218 |
|